Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

42.13
Delayed Data
As of 4:01pm ET
 -0.29 / -0.68%
Today’s Change
36.71
Today|||52-Week Range
46.10
+5.90%
Year-to-Date
GSK Regular Dividend: GSK will begin trading ex-dividend on 05/11/16 with a $0.5542 dividend payable to shareholders of record as of 05/13/16.

Today’s Trading

Previous close42.42
Today’s open42.11
Day’s range41.81 - 42.24
Volume2,646,896
Average volume (3 months)3,732,875
Market cap$103.3B
Dividend yield5.55%
Data as of 4:01pm ET, 05/06/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+13.47%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-3.66%
P/E ratio167.7
Price/Sales2.70
Price/Book13.62

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.12-0.31%
NVONovo Nordisk-0.19-0.35%
ABBVAbbVie+0.17+0.27%
BMYBristol-Myers Squibb+0.07+0.10%
Data as of 4:02pm ET, 05/06/2016

Financials

Next reporting dateJuly 20, 2016
EPS forecast (this quarter)$0.57
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Partner Offers

Search for Jobs